Author(s): Costa, F ; Guerreiro, JP ; Melo, M ; Miranda, AC ; Martins, AP ; Garção, J ; Madureira, B
Date: 2019
Origin: Revista Portuguesa de Farmacoterapia
Author(s): Costa, F ; Guerreiro, JP ; Melo, M ; Miranda, AC ; Martins, AP ; Garção, J ; Madureira, B
Date: 2019
Origin: Revista Portuguesa de Farmacoterapia
ObjectivePoor compliance to antihypertensive medications has been identified as a primary cause of uncontrolled blood pressure (BP), with consequent increases in hypertension-related morbidity and mortality. Therefore, any measure known to improve compliance should be encouraged. This study assessed the impact of reminder cards on compliance to antihypertensive therapy. MethodA field trial was undertaken in pharmacies located in the districts of Lisbon and Porto. Eligible participants comprised those aged 30–74 years, prescribed an angiotensin-converting enzyme inhibitor (ACEI) in monotherapy, and taken on a once-daily regimen. Patients were allocated to control group (CG) or intervention group (IG), the latter being provided with a reminder card, an alarm-type device due to remind the patient of the time to take his medication. Patients were monthly monitored during 3 months for compliance and blood pressure control. Key findingsSeventy-one patients participated in the study (intervention: 35; control group: 36). Compliance was similar between the groups in the first 2 months of follow-up (97.1% IG vs 94.9% CG at first follow-up and 97.5% IG vs 94.2% CG at second follow-up) and higher in the intervention group at the end of the study (97.3% IG vs 87.3% CG; P¼ 0.011). There were no mean blood pressure differences between compliant and non-compliant subjects at the end of the study (P value for differences in systolic BP (Psyst=0.580; and P value for differences in diastolic BP (Pdiast=0.175). ConclusionThis small-scale study indicates a possible positive impact on patients’ compliance resulting from the use of reminder cards. However, this needs confirming in larger scale studies with longer monitoring periods. Published in: Int J Pharm Pract. 2005: 13; 205-11.